In the UK there has of course been great debate on Brexit – each side fighting its cause and every sector obviously having an opinion on what it would mean if the country does or doesn’t leave the EU
Simon Tilley, head of pharmaceuticals, SAS UK and Ireland talks about how organisations can finalise a strategy for compliance with Identification of Medicinal Products (IDMP) standards and the opportunities that it can provide
George Freeman, British minister for life sciences has said that if Britain was to leave the EU, it would make the UK, Europe and the globe a “less secure place and hinder not help the process of global trade”
Researchers at the University of Southern California (USC) and NASA’s Jet Propulsion Laboratory have come up with idea of launching fungi into space to create new medicine
Darren Andrews, business development director, Cobalt Light Systems, outlines the way that Transmission Raman spectroscopy is replacing HPLC and more in QC laboratories
The O’Neill review into antimicrobial resistance (AMR) challenges governments, industry and the medical profession to get to grips with bacterial resistance to antibiotics, “one of the biggest health threats facing mankind”
Johan Frieling has recently been appointed as the new chief medical officer of Micreos. EPM talks to him about his experience in the pharmaceutical sector and the company’s new antibiotic alternative, Staphefekt
Scott Weiss, senior director of product management, IDBS talks about the Internet of Things (IoT) and externalised research and development (R&D) in life sciences
